HKD 13.74
(-2.69%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -172.57 Million CNY | 41.5% |
2022 | -224.64 Million CNY | -15.83% |
2021 | -287.01 Million CNY | -60.78% |
2020 | -190.4 Million CNY | -116.01% |
2019 | -95.48 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -50.98 Million HKD | 43.37% |
2024 Q2 | -50.55 Million HKD | 0.15% |
2023 Q2 | -105.28 Million HKD | -70.8% |
2023 Q3 | -73.53 Million HKD | 30.15% |
2023 FY | - CNY | 41.5% |
2023 Q1 | -61.64 Million HKD | 67.83% |
2023 Q4 | -119.11 Million HKD | -61.97% |
2022 Q2 | -191.38 Million HKD | 0.0% |
2022 FY | - CNY | -15.83% |
2022 Q4 | -191.6 Million HKD | -60.65% |
2022 Q3 | -119.26 Million HKD | 37.68% |
2021 FY | - CNY | -60.78% |
2020 FY | - CNY | -116.01% |
2019 FY | - HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | 350.667% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | 206.542% |
Human Health Holdings Limited | 104.06 Million HKD | 265.839% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | 159.081% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | 229.165% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | 427.114% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | -290.53% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | 147.954% |
Town Health International Medical Group Limited | 53.5 Million HKD | 422.572% |
Medicskin Holdings Limited | 6.77 Million HKD | 2646.916% |
Hang Chi Holdings Limited | 81.58 Million HKD | 311.528% |